Triplet therapies – the new standard of care for multiple myeloma: how to manage common toxicities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Triplet therapies – the new standard of care for multiple myeloma: how to manage common toxicities

Published:2018-12-02 Issue:12 Volume:11 Page:957-973
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Paner Agne¹,Okwuosa Tochukwu M.²,Richardson Kristin J.¹,Libby Edward N.³

Affiliation:

1. Division of Hematology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA

2. Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA

3. Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2018.1538777

Reference137 articles.

1. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

2. A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

3. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

4. Improved survival in multiple myeloma and the impact of novel therapies

5. Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antitumoral Agent-Induced Constipation: A Systematic Review;Cancers;2023-12-24

2. Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption;Cell Stem Cell;2021-04

3. Care Delivery and Treatment Decision Making: Bioethical and Nursing Considerations During and After the COVID-19 Pandemic;Clinical Journal of Oncology Nursing;2021-02-01

4. Melflufen for relapsed and refractory multiple myeloma;Expert Opinion on Investigational Drugs;2020-09-29

5. Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma;Journal of Clinical Medicine;2020-09-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3